Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Helping modern organizations thrive requires a different kind of leadership. The Executive Development Program supports high-performing managers as they step into broader leadership roles. Through an ...

Two solid-value approaches, one well-built ETF. Our research team assigns Gold ratings to strategies that they have the most conviction will outperform their Morningstar Category average over a market ...

On September 12, 2025, EPA released a proposal to permanently remove program obligations for 46 source categories of the GHGRP in accordance with President Trump's Executive Order 14192, "Unleashing ...

The Stanford Neurosciences Interdepartmental Program (IDP) offers interdisciplinary training leading to a Ph.D. in Neuroscience. The primary goal of the program is to train students to become leaders ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...